CR Ventures: A global life-science investor specializing in medical tech clinical trials.
Location
Boston, MA, US
Founded
2019
CR Ventures is a global life-science investor focusing exclusively on companies seeking funding for clinical trials in pharmaceuticals, diagnostics, and other medical technologies. The firm does not invest in purely pre-clinical rounds, emphasizing their commitment to later-stage developments. CR Ventures operates from offices in Boston and Europe, investing globally in the life sciences sector.
The firm partners with top-tier clinical research organizations to facilitate rapid start-up, enrollment, and successful trial completion for their portfolio companies. Notable investments include Astrocyte Pharmaceuticals and Xeno Biosciences. CR Ventures typically participates in Series A rounds, offering a unique value proposition through their expertise in clinical trial management and execution.
CR Ventures - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Portfolio Companies2
Current Portfolio Count2
Top Investment Stages
Series A2 (100.0%)
Stage Mix
Series A 100%
Concentration shown as share of disclosed investments by stage.
